Adocia Stock OTC Markets
Stocks
ADOIF
FR0011184241
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 41.99M 47.24M 39.14M 35.68M 67.32M 4.55B 67.92M 474M 184M 2.32B 177M 174M 7.44B | P/E 2026 * |
-2.62x | P/E 2027 * | 3.1x |
|---|---|---|---|---|---|
| Enterprise Value | 46.39M 52.19M 43.24M 39.42M 74.37M 5.03B 75.03M 524M 203M 2.56B 196M 192M 8.22B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 1.61x |
| Free-Float |
93.92% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -5.93% |
| Manager | Title | Age | Since |
|---|---|---|---|
Olivier Soula
CEO | Chief Executive Officer | 55 | 11/05/2023 |
| Director of Finance/CFO | - | 23/09/2024 | |
Martin Gaudier
CTO | Chief Tech/Sci/R&D Officer | - | 01/12/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Olivier Soula
BRD | Director/Board Member | 55 | 19/04/2013 |
Stéphane Boissel
CHM | Chairman | 57 | - |
Mads Dall
BRD | Director/Board Member | 61 | 11/05/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.93% | -12.50% | - | - | 47.26M | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.16B | |
| -3.11% | -3.53% | +21.92% | +74.60% | 57.39B | |
| +0.89% | -0.63% | +4.28% | +34.51% | 47.64B | |
| +0.36% | +0.81% | +352.17% | +689.61% | 44.29B | |
| -0.96% | -4.50% | +26.36% | +33.18% | 42.5B | |
| -0.20% | -0.77% | +3.74% | +100.60% | 40.71B | |
| -0.54% | +2.93% | +9.31% | +50.41% | 30.97B | |
| -2.68% | +2.92% | +29.63% | +19.50% | 28.53B | |
| +0.05% | -1.64% | -7.28% | -14.06% | 24.34B | |
| Average | -0.80% | -0.59% | +54.39% | +120.28% | 43.39B | |
| Weighted average by Cap. | +0.12% | -0.84% | +58.77% | +129.91% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 44.87M 50.48M 41.82M 38.12M 71.93M 4.86B 72.57M 507M 197M 2.48B 189M 185M 7.95B |
| Net income | -16M -18M -14.91M -13.6M -25.65M -1.73B -25.88M -181M -70.09M -884M -67.58M -66.12M -2.84B | -44.33M -49.87M -41.32M -37.67M -71.07M -4.8B -71.7M -501M -194M -2.45B -187M -183M -7.86B |
| Net Debt | 4.4M 4.95M 4.1M 3.74M 7.05M 477M 7.12M 49.7M 19.28M 243M 18.58M 18.18M 780M | 30.18M 33.95M 28.13M 25.64M 48.38M 3.27B 48.81M 341M 132M 1.67B 127M 125M 5.35B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
